Developing and Validating an Individual-Level Deprivation Index for Children's Health in France

Int J Environ Res Public Health. 2022 Dec 16;19(24):16949. doi: 10.3390/ijerph192416949.

Abstract

Background: Deprivation generates many health inequalities. This has to be taken in account to enhance appropriate access to care. This study aimed to develop and validate a pediatric individual-level index measuring deprivation, usable in clinical practice and in public health.

Methods: The French Individual Child Deprivation Index (FrenChILD-Index) was designed in four phases: item generation then reduction using the literature review and expert opinions, and index derivation then validation using a cross-sectional study in two emergency departments. During these last two phases, concordance with a blinded evaluation by an expert enabled us to determine thresholds for two levels of moderate and severe deprivation.

Results: The generation and reduction phases retained 13 items. These were administered to 986 children for the derivation and validation phases. In the validation phase, the final 12 items of the FrenChILD-Index showed for moderate deprivation (requiring single specific care for deprived children) a sensitivity of 96.0% [92.6; 98.7] and specificity of 68.3% [65.2; 71.4]. For severe deprivation (requiring a multidisciplinary level of care), the sensitivity was 96.3% [92.7; 100] and specificity was 91.1% [89.2; 92.9].

Conclusions: The FrenChILD-Index is the first pediatric individual-level index of deprivation validated in Europe. It enables clinical practice to address the social determinants of health and meet public health goals.

Trial registration: ClinicalTrials.gov NCT03640715.

Keywords: access to health care; deprivation; health inequalities; screening; social determinants of health; social support.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Child Health*
  • Cross-Sectional Studies
  • Europe
  • France
  • Humans
  • Social Factors*
  • Socioeconomic Factors

Associated data

  • ClinicalTrials.gov/NCT03640715

Grants and funding

This research was funded by the Agence Regionale de Santé Provence Alpes Côte d’Azur, Marseille France (Grant C2016000613) and Partial financial support was received from the Conseil Départemental des Bouches du Rhône for the organization of the steering and reading committees.